Systemic psoriasis biomarkers differentially impact clinical responses to deucravacitinib and apremilast in moderate-to-severe plaque psoriasis: Insight from phase 3 studies

Journal of Investigative Dermatology · Elsevier

Аннотация

Publication date: Available online 7 November 2026 Source: Journal of Investigative Dermatology Author(s): Yi Luo, Aditi B. Bal, Peter Schafer, James G. Krueger

Читать у издателя →

Похожие статьи